EFG Asset Management North America Corp. Lowers Stock Position in Astera Labs, Inc. $ALAB

EFG Asset Management North America Corp. lessened its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 17.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,561 shares of the company’s stock after selling 4,644 shares during the period. EFG Asset Management North America Corp.’s holdings in Astera Labs were worth $4,220,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Great Valley Advisor Group Inc. lifted its holdings in shares of Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after acquiring an additional 90 shares during the last quarter. Straight Path Wealth Management raised its position in Astera Labs by 1.5% during the second quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock valued at $619,000 after purchasing an additional 100 shares in the last quarter. Rye Brook Capital LLC lifted its stake in Astera Labs by 1.1% during the third quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after purchasing an additional 100 shares during the last quarter. First Horizon Advisors Inc. lifted its stake in Astera Labs by 12.4% during the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after purchasing an additional 108 shares during the last quarter. Finally, Merit Financial Group LLC boosted its holdings in shares of Astera Labs by 3.1% in the 3rd quarter. Merit Financial Group LLC now owns 5,683 shares of the company’s stock worth $1,113,000 after purchasing an additional 170 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $163.25 on Tuesday. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The company’s 50 day moving average price is $162.24 and its 200-day moving average price is $170.29. The stock has a market capitalization of $27.57 billion, a price-to-earnings ratio of 147.07, a P/E/G ratio of 2.31 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm’s revenue was up 103.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity

In other news, General Counsel Philip Mazzara sold 4,620 shares of the stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $668,467.80. Following the completion of the sale, the general counsel directly owned 147,040 shares in the company, valued at approximately $21,275,217.60. This represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Sanjay Gajendra sold 90,459 shares of the firm’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief operating officer directly owned 1,599,750 shares in the company, valued at $231,467,827.50. The trade was a 5.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 576,936 shares of company stock valued at $87,409,540. 12.50% of the stock is owned by corporate insiders.

Analyst Ratings Changes

ALAB has been the topic of a number of research reports. Royal Bank Of Canada initiated coverage on Astera Labs in a report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price objective on the stock. Raymond James Financial initiated coverage on shares of Astera Labs in a research report on Friday, November 21st. They set a “hold” rating on the stock. Morgan Stanley restated an “overweight” rating and issued a $210.00 price objective on shares of Astera Labs in a report on Wednesday, December 3rd. Bank of America assumed coverage on shares of Astera Labs in a research note on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price objective for the company. Finally, Needham & Company LLC increased their target price on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $190.63.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.